The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes
Open accessAbstract
Distinguishing patients with monogenic diabetes from those with type 1 diabetes (T1D) is important for correct diagnosis, treatment, and selection of patients for gene discovery studies. We assessed whether a T1D genetic risk score (T1D-GRS) generated from T1D-associated common genetic variants provides a novel way to discriminate monogenic diabetes from T1D. The T1D-GRS was highly discriminative of proven maturity-onset diabetes of young (MODY) (n = 805) and T1D (n = 1,963) (receiver operating characteristic area under the curve 0.87). A T1D-GRS of >0.280 (>50th T1D centile) was indicative of T1D (94% specificity, 50% sensitivity). We then analyzed the T1D-GRS of 242 white European patients with neonatal diabetes (NDM) who had been tested for all known NDM genes. Monogenic NDM was confirmed in 90, 59, and 8% of patients with GRS <5th T1D centile, 50–75th T1D centile, and >75th T1D centile, respectively. Applying a GRS 50th T1D centile cutoff in 48 NDM patients with no known genetic cause identified those most likely to have a novel monogenic etiology by highlighting patients with probable early-onset T1D (GRS >50th T1D centile) who were diagnosed later and had less syndromic presentation but additional autoimmune features compared with those with proven monogenic NDM. The T1D-GRS is a novel tool to improve the use of biomarkers in the discrimination of monogenic diabetes from T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Self-citationThe Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationGenetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationTodd, J. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.001 · Cited by 560
De Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Self-citationClinical Applications of Diabetes Antibody Testing
Bingley, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1365 · Cited by 278
Oram, R. A., McDonald, T. J., Shields, B. M., Hudson, M. M., Shepherd, M. H., Hammersley, S., Pearson, E. R., Hattersley, A. T., & on behalf of the UNITED Team (2015) · Diabetes Care · doi:10.2337/dc14-0871 · Cited by 133
Self-citation
Research works printed but not linked: 18
- McCarthy, 2008, Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes, Diabetes, 57, 2889, 10.2337/db08-0343 · DOI
- Onengut-Gumuscu, 2015, Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers, Nat Genet, 47, 381, 10.1038/ng.3245 · DOI · Paper page
- Bradfield, 2011, A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci, PLoS Genet, 7, e1002293, 10.1371/journal.pgen.1002293 · DOI · Paper page
- Winkler, 2014, Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes, Diabetologia, 57, 2521, 10.1007/s00125-014-3362-1 · DOI
- Oram, 2016, A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults, Diabetes Care, 10.2337/dc15-1111 · DOI · Paper page
- Törn, 2015, Role of type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY Study, Diabetes, 10.2337/db14-1497 · DOI
- Ellard, 2013, Improved genetic testing for monogenic diabetes using targeted next-generation sequencing, Diabetologia, 56, 1958, 10.1007/s00125-013-2962-5 · DOI · Paper page
- McDonald, 2011, Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from type 1 diabetes, Diabet Med, 28, 1028, 10.1111/j.1464-5491.2011.03287.x · DOI · Paper page
- Decochez, 2000, High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry, Diabetes Care, 23, 838, 10.2337/diacare.23.6.838 · DOI
- Besser, 2011, Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes, Diabetes Care, 34, 286, 10.2337/dc10-1293 · DOI
- Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes, Diabetologia, 55, 1265, 10.1007/s00125-011-2418-8 · DOI · Paper page
- Talmud, 2013, Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study, Lancet, 381, 1293, 10.1016/S0140-6736(12)62127-8 · DOI · Paper page
- Edghill, 2006, HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months, Diabetes, 55, 1895, 10.2337/db06-0094 · DOI
- Iafusco, 2002, Permanent diabetes mellitus in the first year of life, Diabetologia, 45, 798, 10.1007/s00125-002-0837-2 · DOI
- Chang, 2012, Neonatal autoimmune diseases: a critical review, J Autoimmun, 38, J223, 10.1016/j.jaut.2011.11.018 · DOI
- Flanagan, 2014, Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease, Nat Genet, 46, 812, 10.1038/ng.3040 · DOI · Paper page
- Krischer, 2015, The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study, Diabetologia, 58, 980, 10.1007/s00125-015-3514-y · DOI · Paper page
- Lernmark, 2013, Immune therapy in type 1 diabetes mellitus, Nat Rev Endocrinol, 9, 92, 10.1038/nrendo.2012.237 · DOI
Cited by
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897
Mayer-Davis, E. J., Kahkoska, A. R., Jefferies, C., Dabelea, D., Balde, N., Gong, C. X., Aschner, P., & Craig, M. E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12773 · Cited by 682
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
Thomas, N. J., Jones, S. E., Weedon, M. N., Shields, B. M., Oram, R. A., & Hattersley, A. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30362-5 · Cited by 417
Self-citationRyan, P. M., & Caplice, N. M. (2020) · Obesity · doi:10.1002/oby.22843 · Cited by 321
Metadata
- Authors
- Patel, K. A., Oram, R. A., Flanagan, S. E., De Franco, E., Colclough, K., Shepherd, M., Ellard, S., Weedon, M. N., & Hattersley, A. T.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-04-05
- Volume
- 65
- Issue
- 7
- Pages
- 2094-2099
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2313889229
- Cited by
- 195
- References
- 8
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Wellcome Trust (076113)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/db15-1690
- The paper
- Patel, K. A., Oram, R. A., Flanagan, S. E., De Franco, E., Colclough, K., Shepherd, M., Ellard, S., Weedon, M. N., & Hattersley, A. T. (2016). Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db15-1690
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.